It offers improved efficacy and toxicity characteristics compared to its sister compounds, lenalidomide and thalidomide.508 In MM cells, which heavily rely on various transcription factors, pomalidomide has been observed to inhibit NF-κB transcription and suppress COX-2 gene transcription activity, contributing to its therapeutic effects.509. Here, NFKB1 is linked to Miyoshi myopathy.